Bioinformatics Data Articles & Analysis
25 news found
This platform combines artificial intelligence and machine learning to streamline data processing, analysis, and model construction throughout the drug development process. Equipped with robust tools and algorithms, the CADD platform aids in target identification, molecular library screening, drug activity prediction, and optimization. Leveraging big data and ...
Profacgen, a biotechnology company that offers bioinformatics platform to help academic and industrial researchers to explore, understand and analyze complex biological data in various biotechnological programs and projects, recently updated its in silico protein-protein interactions prediction service to meet diversified needs of its customers. ...
The Bioinformatics-Analysis, a subdivision of CD Genomics, provides reliable next-generation and third-generation high-throughput sequencing data analysis, comprehensive technology services, database construction, and other related data analysis services. CD Genomics provides metatranscriptome sequencing data analysis service ...
DNAnexus, Inc., the leading provider of cloud-based genomic and biomedical data access and companion analysis software, today announced the speaker lineup for its customer presentations at the American Society of Human Genetics (ASHG) 2022 Annual Meeting, which is being held in Los Angeles this week. ...
By mapping population-level adverse drug reaction data extracted from the U.S. Food and Drug Administration (FDA) Adverse Event Reporting System back to molecular pathways and target profile data, the two proof-of-concept studies examined potential causes of cardiotoxicity and of colitis associated with well-known targeted cancer therapies. ...
The Biomedical Bioinformatics Platform belongs to CD Genomics and has a good reputation for assisting researchers with data analysis challenges, including NGS data processing, analysis, interpretation, and general genomic data analysis, as well as data mining, statistical modeling, data ...
The company will intensify investments in the development of its genomic-aware data lake to improve the use of big data and machine learning approaches in genomic analysis with the aim of better addressing the fast-evolving needs of molecular biology labs that provide genomic analysis in clinical routine environments, as well as to biopharma companies developing ...
Bioinformatics-analysis Platform belongs to CD Genomics, which provides reliable next-generation and third-generation high-throughput sequencing data analysis, comprehensive technology services, database construction, and other related data analysis business. The platform is a leading open solution for data-driven innovation, ...
JADBio and BioLizard today announced their partnership. BioLizard is an agile bioinformatics and AI/ML company globally servicing clients in the life sciences, biotechnology and pharmaceutical industries. ...
ByJADBio
Bioinformatics-analysis Platform belongs to CD Genomics, which provides reliable next-generation and third-generation high-throughput sequencing data analysis, comprehensive technology services, database construction, and other related data analysis business. ...
Bioinformatics focuses on developing methods and software tools for understanding biological data using mathematical and statistical techniques. As an interdisciplinary research field, it has become an important part of biological research nowadays in the storage, analysis and interpretation of experimental data. The field of ...
“With MH Guide, doctors can manage the flood of data from molecular genetic testing and translate it into targeted therapy recommendations. ...
The software enables the automatic analysis of molecular data obtained using Next Generation Sequencing (NGS), and provides treating physicians with an evidence-based report for personalized therapy approaches. ...
The company can also help discover biomarkers after interpreting proteomics data through powerful bioinformatics technology. Extracellular vesicles are vesicle-like bodies with a double-layer membrane structure that fall off the cell membrane or are secreted by cells, and are mainly composed of microvesicles, apoptotic bodies, and exosomes. ...
To systematically advance the decoding of the disease, clinical data from up to 2,000 COVID-19 patients treated at the Universitätsmedizin Essen will be analyzed and linked to the digital model to identify new drug targets and biomarkers. ...
To do this, MH Guide matches molecular patient data with data derived from one of the largest growing and Molecular Health-owned knowledge platforms (Dataome). ...
The combination of real-life data sets in rare diseases with innovative big data/artificial intelligence/novel scientific computational knowledge will transform biomedical research, product development, and therapy. Real-life data and Innovative Bioinformatic Algorithms (RIBA project) will enable the creation of a powerful ...
Assay technologies make these biomolecules visible and ready for analysis. Bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. ...
MedBiome is pleased to announce that it has licensed the iMetaLab software platform from the University of Ottawa. iMetaLab (imetalab.ca) is a leading bioinformatics software for metaproteomics data analysis. MedBiome uses the iMetaLab software in combination with the RapidAIM assay to identify Precision Microbiome Therapeutics that change the ...
Greenberg, MD, identifies biological components of autoimmune disease and immunological response to cancer through bioinformatics and clinical disease observation. These insights lead to identification of novel drug targets expressed by discrete subpopulations of the immune system that can be modulated for therapeutic uses. ...